This page shows the latest Non-24 news and features for those working in and with pharma, biotech and healthcare.
Preliminary analysis found that the UK COVID-19 variant was detected in over 50% of the PCR-test confirmed cases – with 32 cases being caused by the UK variant, 24 by ... the non-variant and six ‘unknown’.
In addition, preliminary analysis found that the UK variant was detected in over 50% of the PCR-confirmed cases – with 32 cases being caused by the UK variant, 24 by the ... non-variant and six ‘unknown’.
In addition, preliminary analysis found that the UK variant was detected in over 50% of the PCR-confirmed cases – with 32 cases being caused by the UK variant, 24 by the ... non-variant and six ‘unknown’.
In addition, preliminary analysis found that the UK variant was detected in over 50% of the PCR-confirmed cases – with 32 cases being caused by the UK variant, 24 by the ... non-variant and six ‘unknown’.
In a statement, Novartis said that Sandoz will offer "financial assistance to qualified patients, personalised injection training and 24-hour access to nurses for non-clinical questions" as part of the
FDA approval as a second-line non-small cell lung cancer (NSCLC) therapy - a much larger market opportunity - in March. ... Vanda Pharmaceuticals got the go-ahead for Hetlioz (tasimelteon) for the treatment of non-24-hour sleep wake disorder in totally
More from news
Approximately 1 fully matching, plus 14 partially matching documents found.